St. Jude Announces CRM Approvals, Progress With Warning Letter
This article was originally published in The Gray Sheet
Executive Summary
FDA approval of several St. Jude Medical’s new cardiac rhythm management devices, including a new defibrillator lead, suggest the agency is largely satisfied with the company’s steps to resolve a January 2013 warning letter.